PESG is a digital thought brand offering commentary, posts and exploration into the current and future state of the Pharma, ESG and sustainability industries.
Learn MOre

About PESG

Cutting-edge research for the future of pharma, ESG & Sustainability

PESG Research is a digital brand under the Future Markets Research Tank (FMRT). FMRT brings together thought leaders in of some of the most critical industries for the future of mankind. Together, they examine the scientific, economic and technological ramifications of emerging technologies and industries. Our unique staff and their diverse backgrounds provide a first of its kind opportunity to reach conclusions on matters concerning the future of the cyber, cannabis, pharma, food and other industries.

Our international orientation and disciplinary approach are what make us unique in our outlook on these  areas, providing us with a distinct perspective.
Recent  PostsRead Disclaimers

Recent Publications and POST

Exploring the future of critical industries such as cyber, pharma, food, cannabis and more.

PESG Releases Commentary on Steakholder Foods and the Culture Meat Revolution

PESG Research, a research group under the Future Markets Research Tank (FMRT), in proud to release an industry report on the emerging cultured food market, featuring Steakholder Foods, an innovative cultured meat leader.

Access the Report

The Decentralized Think Tank’s Market Commentary on The INX Digital Company

The Decentralized Think Tank, a member of The Future Markets Research Tank (FMRT), is glad to present its blog on INX ($INXD), the SEC-approved platform the allows companies to seek funding via digital tokens.

Access the Report

Future Markets Research Names  Ten Leading Companies Who Are Building the Metaverse

We're proud to present a blog analyzing the top companies building the metaverse. The report focuses on three pillars of metaverse activity: Full platforms, Technological Infrastructure, and Hyperrealism.

Access the Report

PESG Research Releases Market Commentary on Innocan Pharma and CBD-Vet Industry

We're proud to release amarket commentary blog on Innocan Pharma, an up-and-coming leader in the CBD veterinary. In the report, we covered several leading companies in the field, with an emphasis on Innocan Pharma.

Access the Report

Get in Touch

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

© Pharma & ESG Sustainability Group (PESG), all rights reserved.
A brand associated with the Future Market Research Tank

DISCLAIMERSFollow us On Twitter

Disclaimer: The author(s)/brand(s) is compensated to provide independent analysis of companies. Market commentary is individual opinion and should not serve as any form of advice. You must always do your own research. "Future Markets Research Tank" or any names, brands or accounts associated with it are digital brand names and do not seek to be any form of financial advisor or equity research organization. We may operate under a number of pseudonyms. We received monetary compensation for  the content and thoughts presented above and that should be taken into account when reading any content presented. While our content generally focused on science, technology, and industry analysis, it may mention the public markets or companies that happen to be traded. It should be clear that our content is not investment advice. The stock market is volatile and investors are advised to do their own research prior to making a decision. Do Not Use Any Information in Our Publications, social media channels or anything else associate with our brand to Make an Investment Decision. There is no information on our website or distributed otherwise that should be used as the basis for an investment decision. We do not act, directly or indirectly, in the capacity of any of the following and you should not construe our activities as involving any of the following: (a) investment advisor; (b) broker dealer; (c) broker; (d) dealer; (e) stock recommender; (f) stock picker; (g) finder; (h) securities trading expert; (i) financial planner; (j) engaging in the offer and sale of securities; (k) securities analyst; (l) financial analyst; (m) providing price targets or buy or sell recommendations. Our activities may involve multiple potential and/or actual conflicts of interest - we may receive monetary or securities compensation in tied to the industries or companies we are we are researching. The third party shareholder from which we receive compensation also has an actual conflict of interest since he or she or it is paying us securities compensation for research services and such non-affiliate third party shareholder may sell other shares held while we are promoting the issuer that issues the stock held by such third party shareholder. There are no implied or express warranties regarding the contents of our Publications.